OnKure Therapeutics Statistics
Total Valuation
OKUR has a market cap or net worth of $111.78 million. The enterprise value is $110.33 million.
Important Dates
The next estimated earnings date is Friday, February 14, 2025, before market open.
| Earnings Date | Feb 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OKUR has 13.34 million shares outstanding.
| Current Share Class | 12.65M |
| Shares Outstanding | 13.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 17.25% |
| Owned by Institutions (%) | 10.23% |
| Float | 1.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65
| Current Ratio | 0.65 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -192.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.60% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -42.60% |
| 50-Day Moving Average | 15.50 |
| 200-Day Moving Average | 15.91 |
| Relative Strength Index (RSI) | 20.06 |
| Average Volume (20 Days) | 136,520 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -45.58M |
| Pretax Income | n/a |
| Net Income | -44.69M |
| EBITDA | -45.12M |
| EBIT | -45.58M |
| Earnings Per Share (EPS) | -$3.35 |
Full Income StatementBalance Sheet
The company has $7.96 million in cash and $6.51 million in debt, giving a net cash position of $1.45 million or $0.11 per share.
| Cash & Cash Equivalents | 7.96M |
| Total Debt | 6.51M |
| Net Cash | 1.45M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | -5.23M |
| Book Value Per Share | -10.08 |
| Working Capital | -6.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.78 million and capital expenditures -$70,000, giving a free cash flow of -$34.85 million.
| Operating Cash Flow | -34.78M |
| Capital Expenditures | -70,000 |
| Free Cash Flow | -34.85M |
| FCF Per Share | -$2.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |